Tuesday, June 16, 2026

How Samsung’s On-Device AI is Transforming Emergency Ultrasound Diagnostics in 2026

Samsung Medical Center is developing AI ultrasound tech for emergency care, enhancing diagnostics with real-time, on-device capabilities.

Dubai Chocolate Goes Global: Starbucks Korea Launches Two Iced Drinks Fans Could Only Get in the U.S. and Canada

Starbucks Korea will launch Iced Dubai Chocolate beverages on February 11, responding to customer demand for these popular drinks.

Drone Warfare Escalates: Insights into North Korea’s Claims and the Implications for Regional Security

North Korea claims it shot down a South Korean drone intruding its airspace, asserting it was for reconnaissance purposes.

Health

How AI-Powered Ultrasound is Transforming Cardiovascular Diagnosis in Asia

UltraSight and Mediana collaborate on an AI-driven cardiovascular diagnostic platform, enhancing patient monitoring and disease management.

How Samsung’s On-Device AI is Transforming Emergency Ultrasound Diagnostics in 2026

Samsung Medical Center is developing AI ultrasound tech for emergency care, enhancing diagnostics with real-time, on-device capabilities.

Noel Wins Government Backing to Accelerate Expansion in Europe and Latin America

Noel, an AI diagnostics firm, joins South Korea's Global SME 1000+ Project to enhance global expansion and strengthen market presence.

CARTISTEM vs. Traditional Treatments: What Makes Medipost’s Stem Cell Therapy a Game-Changer?

Medipost to commercialize CARTISTEM in Japan using domestically produced media, enhancing supply chain stability and competitiveness.

Can Donanemab Expand Alzheimer’s Treatment to Lewy Body Dementia? Key Insights from Korean Lilly’s Latest Clinical Trials

Lilly has launched a global trial for Kisunla, targeting Lewy body dementia, aiming to expand its Alzheimer's treatment to this underserved area.

South Korea Steps Up Ebola Screening Amid Central Africa Outbreaks

KDCA reviews Ebola preparedness at Incheon Airport amid outbreaks in Africa, ensuring strict quarantine measures for travelers.

Wegovy, Mounjaro Boom Creates New Winners as Ursa, InBody Ride GLP-1 Ripple Effects

GLP-1 obesity drugs are boosting gallstone prevention therapies and body composition monitoring, creating new market opportunities.

Daewoong Pharmaceutical Expands Biosimilar Push With Dupixent Copy Deal and Global CDMO Partnership

Daewoong Pharmaceutical partners with Chime Biologics to develop a Dupixent biosimilar, enhancing its global biosimilar business expansion.

Hallym Opens Korea’s First Refractory Itch Center as Chronic Pruritus Cases Grow More Complex

A patient with chronic itch was diagnosed with senile atopic dermatitis, highlighting the need for accurate diagnosis and specialized treatment.

Bukwang Pharma Wins Phase 3 Approval to Expand Latuda Into Adjunctive Treatment for Major Depression

Bukwang Pharmaceutical received approval for a Phase 3 clinical trial of Lurasidone as an adjunctive treatment for MDD.

JNPMedi Secures ISO 13485 Certification, Strengthening Its Medical Device Consulting Credibility

JNPMedi has achieved ISO 13485 certification, enhancing its quality management for clinical research and regulatory consulting in medical devices.

Wontech Expands Asian Medical Aesthetics Push Through Wave Brand Events in China and Taiwan

Wontech successfully hosted global brand events in China and Taiwan, enhancing engagement with healthcare professionals and showcasing products.

Daewoong’s Envlo Matches Established SGLT-2 Drugs in Landmark Head-to-Head Diabetes Study

Daewoong Pharmaceutical's Envlo shows promising results in diabetes treatment, comparing favorably to existing SGLT-2 inhibitors in a clinical study.

Mediwhale Expands Global Digital Health Push With New European Certification for AI Retinal Risk Analysis

Mediwhale is advancing in digital healthcare with AI retinal analysis, securing funding, and aiming for IPO to enhance disease risk prediction.

SK Bioscience Opens Songdo Headquarters to Families as It Expands Employee-Centered Corporate Culture

SK Bioscience hosted a family open house at its new headquarters, showcasing its vision and engaging activities for employees' families.

3billion Launches Genome-Based Newborn Screening Service Overseas to Expand Early Genetic Diagnosis

3billion launches 3B-NEO, a genomic newborn screening service to identify genetic disorders in infants, enhancing early diagnosis and treatment.

Samjin Pharmaceutical and Aribio Lab Form Vaccine Partnership to Advance Joint Development and Commercialization

Samjin Pharmaceutical partners with Aribio Lab to develop and commercialize vaccines, enhancing market adoption and R&D capabilities.

Sam Chun Dang Pharm Wins EMA Approval for Phase 1 Trial of Oral Insulin Candidate SCD0503

Samchundang Pharmaceutical's oral insulin candidate 'SCD0503' received final approval for Phase 1 clinical trials from EMA.

Samsung Launches GLP-1 Muscle Loss Study With Galaxy Watch8 and Harvard-Linked Hospital

Samsung is researching muscle loss management for GLP-1 drug users, led by the Galaxy Watch 8.

Top News

- Our Sponsors Ad -

Follow us